18
Participants
Start Date
August 17, 2021
Primary Completion Date
August 31, 2024
Study Completion Date
August 31, 2025
autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70
Intranodal administration into an inguinal lymphnode. Two administrations at the same injection site with a four week interval.
ACTIVE_NOT_RECRUITING
Radboud University Medical Centre, Nijmegen
RECRUITING
University Medical Centre Utrecht, Utrecht
ACTIVE_NOT_RECRUITING
Utrecht University, Utrecht
Collaborators (1)
Radboud University Medical Center
OTHER
Utrecht University
OTHER
Trajectum Pharma B.V.
UNKNOWN
Dutch Arthritis Association
INDUSTRY
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Health Holland
OTHER
UMC Utrecht
OTHER